Quebec,
Newfoundland & Labrador say they will not allow cannabis vape sales
Send a link to a friend
[December 05, 2019]
By Nichola Saminather
TORONTO (Reuters) - The Canadian provinces
of Quebec and Newfoundland and Labrador said on Wednesday they would not
allow the sale of cannabis vapes, just weeks before the start of
marijuana derivatives sales, as concerns linger about a possible
connection between the vaping products and severe lung disease.
|
"We will not be selling vaping products on January 1," Fabrice
Giguère, a spokesman for the Société québécoise du cannabis, which
is responsible for marijuana sales in the province, said by email,
adding the province had not officially announced its stance.
All of Quebec's legal cannabis stores are run by the provincial
government, while Newfoundland and Labrador's stores are private.
Earlier on Wednesday, Newfoundland and Labrador, which as Canada's
easternmost province was the first to kick off sales of legal
cannabis last year, said it would not allow cannabis vape products,
but would review the decision in light of any new clinical evidence.

There have been 11 cases of severe lung illnesses in Canada related
to vaping, according to data from the Canadian government, which has
said it is investigating the cause. Three have been in Quebec, and
none in Newfoundland & Labrador.
[to top of second column] |

The U.S. Centers for Disease Control and Prevention on Nov. 21
identified vitamin E acetate, an additive that is often mixed with
marijuana oil in the illicit cannabis market, as a "chemical of
concern."
"The intent of the decision is to protect the health of the people
in this province until there is more evidence about the connection
between cannabis vaping products and severe lung disease," the
Newfoundland and Labrador government said in a statement.
(Reporting by Nichola Saminather; Editing by Chizu Nomiyama and
Peter Cooney)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |